cost-plus drug pricing
Cost‑Plus Drugs Beat Commercial Insurance Co‑Pays 83%
Cost-plus drug pricing beats commercial insurance co-pays in 83% of cases, and pharmacy prices rose 9% nationwide between 2023 and 2024, according to PwC. In practice, cost-plus plans lock drug prices to real production costs, eliminating the hidden mark-ups that drive traditional co-pay spikes. Medical Disclaimer: This article is for